KLK3 and metastatic malignant neoplasm in the lymph nodes: The clinicopathological factors analyzed included age, initial prostate-specific antigen (PSA) levels, pathological T stage, Gleason score, and the presence or absence of lymph node metastasis determined by pathological diagnosis.